Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. - Zannad, F; Kessler, M; Lehert, P; Grünfeld, J P; Thuilliez, C; Leizorovicz, A; Lechat, P (Kidney International, 2006)